Intravitreal Aflibercept Therapy and Treatment Outcomes of Eyes with Neovascular Age-Related Macular Degeneration in a Real-Life Setting: A Five-Year Follow-Up Investigation

被引：0
|
作者：
Reinhard Angermann
Alexander Franchi
Victoria Stöckl
Julia Rettenwander
Tanja Rettenwander
David Goldin
Martin Stattin
Martina T. Kralinger
Claus Zehetner
机构：
[1] Medical University Innsbruck,Department of Ophthalmology
[2] Paracelsus Medical University Salzburg,Department of Ophthalmology
[3] Clinic Landstraße,Department of Ophthalmology
[4] Vienna Healthcare Group,undefined
[5] Karl Landsteiner Institute for Retinal Research and Imaging,undefined
来源：
Ophthalmology and Therapy | 2022年 / 11卷
关键词：
Anti-VEGF; Compliance; Macular degeneration; Nonpersistence; Vision loss;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：559 / 571
页数：12
相关论文
共 50 条
  • [41] Ranibizumab (Lucentis) in neovascular age-related macular degeneration (AMD): five year follow up
    Cvetkova, Nadezhda
    Maerker, David
    Helbig, Horst
    Hoelldobler, Kristina
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [42] Long-Term Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration in a Clinical Setting
    Eleftheriadou, Maria
    Vazquez-Alfageme, Clara
    Citu, Cristina Maria
    Crosby-Nwaobi, Roxanne
    Sivaprasad, Sobha
    Hykin, Philip
    Hamilton, Robin D.
    Patel, Praveen J.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 174 : 160 - 168
  • [43] Long-term Outcomes of Aflibercept Treatment for Neovascular Age-related Macular Degeneration in a Clinical Setting
    Calugaru, Dan
    Calugaru, Mihai
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 174 : 185 - 186
  • [44] Outcomes of Eyes Lost to Follow-up with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Anti-Vascular Endothelial Growth Factor
    Soares, Rebecca Russ
    Mellen, Phoebe
    Garrigan, Hannah
    Obeid, Anthony
    Wibbelsman, Turner D.
    Borkar, Durga
    Ho, Allen C.
    Hsu, Jason
    OPHTHALMOLOGY RETINA, 2020, 4 (02): : 134 - 140
  • [45] Ranibizumab in neovascular age-related macular degeneration: a 5-year follow-up
    Cvetkova, Nadezhda P.
    Hoelldobler, Kristina
    Prahs, Philipp
    Radeck, Viola
    Helbig, Horst
    Maerker, David
    CLINICAL OPHTHALMOLOGY, 2016, 10 : 1047 - 1051
  • [46] Clinical outcomes after switching treatment from intravitreal ranibizumab to aflibercept in neovascular age-related macular degeneration
    Florian M. Heussen
    Qing Shao
    Yanling Ouyang
    Antonia M. Joussen
    Bert Müller
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2014, 252 : 909 - 915
  • [47] CONBERCEPT IN PATIENTS WITH TREATMENT-NAIVE NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN REAL-LIFE SETTING IN CHINA
    Li, Xun
    Luo, Hongmei
    Zuo, Cheng
    Zhang, Zirong
    Zhang, Junjun
    Zhang, Meixia
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (07): : 1353 - 1360
  • [48] Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration and the Risk of Stroke: A 5-Year Follow-up Cohort Study
    Kim, Sung Soo
    Rim, Tyler Hyungtaek
    Lee, Christopher Seungkyu
    Lee, SungChul
    Kim, Do Wook
    Park, Hyun Ju
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [49] Clinical outcomes after switching treatment from intravitreal ranibizumab to aflibercept in neovascular age-related macular degeneration
    Heussen, Florian M.
    Shao, Qing
    Ouyang, Yanling
    Joussen, Antonia M.
    Mueller, Bert
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 252 (06) : 909 - 915
  • [50] Five-Year Follow-up of Nonfibrotic Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials
    Daniel, Ebenezer
    Ying, Gui-shuang
    Kim, Benjamin J.
    Toth, Cynthia A.
    Ferris, Frederick, III
    Martin, Daniel F.
    Grunwald, Juan E.
    Jaffe, Glenn J.
    Dunaief, Joshua L.
    Pan, Wei
    Maguire, Maureen G.
    OPHTHALMOLOGY, 2019, 126 (05) : 743 - 751
12345